Actinium Pharmaceuticals, Inc. (Delaware) (ATNM) Social Stream
ACTINIUM PHARMACEUTICALS INC (ATNM) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ATNM.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-12 | 3 | $45 | $25 | $35 | $5.17 | 576.98% |
| 2022-08-15 | 3 | $45 | $25 | $31.666 | $5.17 | 512.5% |
| 2022-08-25 | 4 | $45 | $16 | $27.75 | $5.17 | 436.75% |
| 2022-09-08 | 4 | $45 | $16 | $26.5 | $5.17 | 412.57% |
| 2022-09-30 | 5 | $45 | $16 | $26.2 | $5.17 | 406.77% |
| 2022-11-03 | 5 | $53 | $18 | $30.2 | $5.17 | 484.14% |
| 2023-02-07 | 5 | $53 | $18 | $31.4 | $5.17 | 507.35% |
| 2023-04-03 | 5 | $53 | $20 | $31.8 | $5.17 | 515.09% |
| 2023-04-04 | 5 | $53 | $20 | $32 | $5.17 | 518.96% |
| 2023-06-30 | 5 | $53 | $20 | $33.75 | $5.17 | 552.8% |
| 2023-08-15 | 5 | $53 | $20 | $33.25 | $5.17 | 543.13% |
| 2023-10-04 | 5 | $50 | $11.6 | $28.32 | $5.17 | 447.78% |
| 2023-11-03 | 5 | $50 | $11.6 | $27.52 | $5.17 | 432.3% |
| 2023-11-10 | 5 | $50 | $11.6 | $24.52 | $5.17 | 374.27% |
| 2023-12-11 | 5 | $50 | $11.6 | $23.72 | $5.17 | 358.8% |
The Trend in the Analyst Price Target
ATNM's average price target has moved up $21.42 over the prior 43 months.
ATNM reports an average of 329.31% for its upside potential over the past 44 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-01 | 5 | 53 | 20.0 | 31.80 | 10.37 | 206.65% |
| 2023-04-03 | 5 | 53 | 20.0 | 31.80 | 9.20 | 245.65% |
| 2023-05-16 | 5 | 53 | 20.0 | 33.75 | 8.41 | 301.31% |
| 2023-11-10 | 5 | 50 | 11.6 | 24.52 | 4.41 | 456.01% |
| 2023-12-11 | 5 | 50 | 11.6 | 23.72 | 4.92 | 382.11% |
ATNM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 47 months, ATNM's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ATNM as an investment opportunity.
- In terms of how ACTINIUM PHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1591.22% of that group.
- ATNM has a lower variance in analysts' estimates than -1413.68% of all US stocks.
- In the context of all US stocks, ACTINIUM PHARMACEUTICALS INC's number of analysts covering the stock is higher than 297.81% of them.
- In the context of stocks in the small market cap category, ACTINIUM PHARMACEUTICALS INC's average analyst price target is greater than 1222.96% of them.
In the Pharmaceutical Products industry, CPRX, HROW, and VNDA are the three stocks most similar to ACTINIUM PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is ATNM a Buy, Hold or Sell? See the POWR Ratings now!